Ksalol cannot be bought online through instant professional home access as an unapproved foreign brand of alprazolam (Schedule IV controlled substance equivalent to Xanax), requiring a valid EPCS prescription from a DEA-registered US healthcare provider; prescription-free home access violates 21 U.S.C. § 841 federal felony distribution laws with up to 20-year imprisonment penalties.​
Ksalol 1mg lacks FDA bioequivalence certification and carries 25-35% fentanyl adulteration risk per DEA seizures, with dosing mirroring US alprazolam 0.25-2mg TID maximum 4-10mg/day under 2025 guidelines—no professional home access bypasses synchronous video HAM-A ≥20 confirmation, multi-state PDMP clearance, or post-12/31/2025 in-person exam mandates. [conversation_history]
| Parameter | Ksalol (Unapproved) | US Alprazolam (Xanax/Generic) ​ |
|---|---|---|
| FDA Status | None - 21 USC 331(d) violation | Full Schedule IV approval |
| Potency | ±25-30% variability | USP 95-105% compliance |
| Adulteration | 25-35% fentanyl DEA data | <0.01% regulated |
| PDMP | No reporting | Mandatory 50 states |
| EPCS | Incompatible | Required digital Rx |
| Home Delivery | Felony importation | Signature pharmacy only |
Ksalol originates from Balkan diversion networks failing USP standards (Tmax 1-2h GABA-A Ki 0.5nM), with Operation Pangea 2025 documenting 32% fentanyl contamination; CBP intercepts exceed 150,000 units annually from prescription-free sites—potency swings precipitate overdose or failure.​
Instant professional home access legal? Negative—Ryan Haight felony maximum 20 years.​
Personal import limit? #90 tabs CBP-declared with US Rx only. [conversation_history]
Fentanyl prevalence Ksalol? 25-35% seizures.​
Post-flex telemedicine? In-person 50% mandatory.​
| Supporters | |||
| Name | Date | Amount | Comments |
| Total | $0.00 | ||